Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | ADK | P55263 | 1/20 | 0.45 |
| ▸ | LTA4H | P09960 | 8/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | SCN4A | P35499 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.37 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.37 |
| ▸ | TTBK1 | Q5TCY1 | 1/20 | 0.36 |
| ▸ | TTBK2 | Q6IQ55 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | BAX | Q07812 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5969677 | 0.80 | NISCH (0.48) | NISCHNPC1RAB9ATTBK1TTBK2 | |
| SCHEMBL4722556 | 0.80 | ALDH1A1 (0.31) | NISCHMTORADKALDH1A1 | |
| SCHEMBL876246 | 0.79 | ALDH1A1 (0.43) | NISCHMTORADKTAAR1ALDH1A1 | |
| SCHEMBL28575785 | 0.79 | KCNA3 (0.48) | NISCHMTORADKTSHRTAAR1 | |
| SCHEMBL943191 | 0.76 | ALDH1A1 (0.38) | TSHRALDH1A1 | |
| SCHEMBL2221480 | 0.74 | F2 (0.58) | — | |
| SCHEMBL5151126 | 0.73 | NISCH (0.69) | NISCHMTORADKLTA4HTSHR | |
| SCHEMBL6947510 | 0.72 | NISCH (0.41) | NISCHNPC1RAB9ATTBK1TTBK2 | |
| SCHEMBL4264926 | 0.72 | TAAR1 (0.52) | NISCHMTORADKLTA4HTSHR | |
| SCHEMBL4722554 | 0.72 | MTOR (0.35) | NISCHMTORADKTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1303791-B1 | MULTICOLOR IMAGING USING MULTIPHOTON PHOTOCHEMICAL PROCESSES | 3M INNOVATIVE PROPERTIES CO (US) | 2009-08-19 | — | — | EP | claimed |
| US-7026103-B2 | Multicolor imaging using multiphoton photochemical processes | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-04-11 | — | — | US | claimed |
| US-20030194651-A1 | Multicolor imaging using multiphoton photochemical processes | 3M INNOVATIVE PROPERTIES COMPANY | 2003-10-16 | — | — | US | claimed |
| EP-1303791-A2 | MULTICOLOR IMAGING USING MULTIPHOTON PHOTOCHEMICAL PROCESSES | 3M Innovative Properties Company (US) | 2003-04-23 | — | — | EP | claimed |
| WO-2001096952-A2 | MULTICOLOR IMAGING USING MULTIPHOTON PHOTOCHEMICAL PROCESSES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-12-20 | — | — | WO | claimed |
| CN-116728973-A | Printing apparatus | 手持产品公司 | 2023-09-12 | — | — | CN | disclosed |
| US-20220411388-A1 | SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | BIAL R&D INVEST S A (PT) | 2022-12-29 | — | — | US | disclosed |
| EP-4031531-A1 | SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | Bial-R&D Investments, S.A. (PT) | 2022-07-27 | — | — | EP | disclosed |
| CN-114787135-A | Substituted imidazole carboxamides and their use in the treatment of medical disorders | 比亚尔R&D投资股份公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-114763033-A | Printing apparatus | 手持产品公司 | 2022-07-19 | — | — | CN | disclosed |
| WO-2021055612-A1 | SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | BIAL-BioTech Investments, Inc. (US) | 2021-03-25 | — | — | WO | disclosed |
| US-9529261-B2 | Color-forming composition, color-forming curable composition, lithographic printing plate precursor and plate making method, and color-forming compound | FUJIFILM CORPORATION (JP) | 2016-12-27 | — | — | US | disclosed |
| EP-1537142-A1 | AKAP18 DELTA, A NOVEL SPLICING VARIANT OF A PROTEIN KINASE A ANCHOR PROTEIN AND THE USE OF THE SAME | Forschungsverbund Berlin e.V. (DE) | 2005-06-08 | — | — | EP | disclosed |
| WO-2004022591-A1 | AKAP18 DELTA, A NOVEL SPLICING VARIANT OF A PROTEIN KINASE A ANCHOR PROTEIN AND THE USE OF THE SAME | FORSCHUNGSVERBUND BERLIN E. V. (DE) | 2004-03-18 | — | — | WO | disclosed |
| EP-0913392-B1 | ETHYLENE DERIVATIVES AND PEST CONTROLLING AGENTS | NISSAN CHEMICAL IND LTD (JP) | 2003-07-02 | — | — | EP | disclosed |
| US-5670526-A | ANTIINFLAMMATORY AGENT, IMMUNOSUPPRESSANT | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-09-23 | — | — | US | disclosed |
| EP-0385330-B1 | Mixtures of dyestuffs comprising azo compounds on the basis of phenylox diazolyl aniline | BASF AG (DE) | 1995-05-17 | — | — | EP | disclosed |
| EP-0385330-A2 | Mixtures of dyestuffs comprising azo compounds on the basis of phenylox diazolyl aniline | BASF Aktiengesellschaft (DE) | 1990-09-05 | — | — | EP | disclosed |
| US-4891432-A | ANTITUMOR AGENTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1990-01-02 | — | — | US | disclosed |
| US-4207328-A | 1-Phenoxy-2-(2,4-dichlorophenyl)-1-imidazol-1-yl-ethan-2-ones and -ols and antimycotic and fungicidal use | BAYER AKTIENGESELLSCHAFT (DE) | 1980-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411388-A1 | SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | GBA1, GAA, CLN6 | NISCH 48/4885MTOR 654/4885ADK 1938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.